126 related articles for article (PubMed ID: 22847319)
1. Assessing the bioequivalence of topical retinoid products by pharmacodynamic assay.
Lehman PA; Franz TJ
Skin Pharmacol Physiol; 2012; 25(5):269-80. PubMed ID: 22847319
[TBL] [Abstract][Full Text] [Related]
2. Cumulative irritation comparison of adapalene gel and solution with 2 tazarotene gels and 3 tretinoin formulations.
Greenspan A; Loesche C; Vendetti N; Georgeian K; Gilbert R; Poncet M; Baker MD; Soto P
Cutis; 2003 Jul; 72(1):76-81. PubMed ID: 12889719
[TBL] [Abstract][Full Text] [Related]
3. Tolerability of clindamycin/tretinoin gel vs. tretinoin microsphere gel and adapalene gel.
Leyden J; Wortzman M; Baldwin EK
J Drugs Dermatol; 2009 Apr; 8(4):383-8. PubMed ID: 19363857
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the cumulative irritation potential of adapalene gel and cream with that of erythromycin/tretinoin solution and gel and erythromycin/isotretinoin gel.
Queille-Roussel C; Poncet M; Mesaros S; Clucas A; Baker M; Soloff AM
Clin Ther; 2001 Feb; 23(2):205-12. PubMed ID: 11293554
[TBL] [Abstract][Full Text] [Related]
5. Facial tolerability of topical retinoid therapy.
Leyden J; Grove G; Zerweck C
J Drugs Dermatol; 2004; 3(6):641-51. PubMed ID: 15624747
[TBL] [Abstract][Full Text] [Related]
6. Cumulative irritation potential of topical retinoid formulations.
Leyden JJ; Grossman R; Nighland M
J Drugs Dermatol; 2008 Aug; 7(8 Suppl):s14-8. PubMed ID: 18724650
[TBL] [Abstract][Full Text] [Related]
7. Cumulative irritancy potential of adapalene cream 0.1% compared with adapalene gel 0.1% and several tretinoin formulations.
Brand B; Gilbert R; Baker MD; Poncet M; Greenspan A; Georgeian K; Soto P
Cutis; 2003 Dec; 72(6):455-8. PubMed ID: 14700217
[TBL] [Abstract][Full Text] [Related]
8. Cumulative irritation potential of adapalene 0.1% cream and gel compared with tretinoin microsphere 0.04% and 0.1%.
Dosik JS; Homer K; Arsonnaud S
Cutis; 2005 Apr; 75(4):238-43. PubMed ID: 15916222
[TBL] [Abstract][Full Text] [Related]
9. Randomised, controlled trial of the efficacy and safety of adapalene gel 0.1% and tretinoin cream 0.05% in patients with acne vulgaris.
Cunliffe WJ; Danby FW; Dunlap F; Gold MH; Gratton D; Greenspan A
Eur J Dermatol; 2002; 12(4):350-4. PubMed ID: 12095880
[TBL] [Abstract][Full Text] [Related]
10. Adapalene gel 0.1% is better tolerated than tretinoin gel 0.025% among healthy volunteers of various ethnic origins.
Goh CL; Tang MB; Briantais P; Kaoukhov A; Soto P
J Dermatolog Treat; 2009; 20(5):282-8. PubMed ID: 19634042
[TBL] [Abstract][Full Text] [Related]
11. [Comparative study of the efficacy and tolerability of 0.1 and 0.03 p.100 adapalene gel and 0.025 p.100 tretinoin gel in the treatment of acne].
Alirezai M; Meynadier J; Jablonska S; Czernielewski J; Verschoore M
Ann Dermatol Venereol; 1996; 123(3):165-70. PubMed ID: 8761775
[TBL] [Abstract][Full Text] [Related]
12. Comparative irritancy study among retinoid creams and gels.
Toole JW; Lockhart L; Potrebka J; Bowman JP; Novack GD
J Cutan Med Surg; 1999 Oct; 3(6):298-301. PubMed ID: 10575158
[TBL] [Abstract][Full Text] [Related]
13. Application of a dermatopharmacokinetic (DPK) method for bioequivalence assessment of topical metronidazole creams.
Rath S; Ramanah A; Bon C; Kanfer I
J Pharm Pharm Sci; 2020; 23():437-450. PubMed ID: 33156995
[TBL] [Abstract][Full Text] [Related]
14. Development of in vivo bioequivalence methodology for dermatologic corticosteroids based on pharmacodynamic modeling.
Singh GJ; Adams WP; Lesko LJ; Shah VP; Molzon JA; Williams RL; Pershing LK
Clin Pharmacol Ther; 1999 Oct; 66(4):346-57. PubMed ID: 10546918
[TBL] [Abstract][Full Text] [Related]
15. Bioequivalence of 0.1% mometasone furoate lotion to 0.1% mometasone furoate hydrogel.
Greive KA; Barnes TM
Australas J Dermatol; 2016 May; 57(2):e39-45. PubMed ID: 25545549
[TBL] [Abstract][Full Text] [Related]
16. Adapalene 0.1% gel and adapalene 0.1% cream stimulate retinoic acid receptor mediated gene transcription without significant irritative effects in the skin of healthy human volunteers.
Griffiths CE; Ancian P; Humphries J; Poncet M; Rizova E; Michel S; Clucas A
Br J Dermatol; 1998 Oct; 139 Suppl 52():12-6. PubMed ID: 9990415
[TBL] [Abstract][Full Text] [Related]
17. Absorption of tretinoin in rats and rabbits following oral and dermal application.
Chou R; Bürgin H; Schmitt G; Eggers H
Arzneimittelforschung; 1997 Apr; 47(4):401-5. PubMed ID: 9150861
[TBL] [Abstract][Full Text] [Related]
18. Development of SLNs from natural lipids: application to topical delivery of tretinoin.
Mandawgade SD; Patravale VB
Int J Pharm; 2008 Nov; 363(1-2):132-8. PubMed ID: 18657601
[TBL] [Abstract][Full Text] [Related]
19. Irritation potential of tretinoin gel microsphere pump versus adapalene plus benzoyl peroxide gel.
Leyden JJ; Nighland M; Rossi AB; Ramaswamy R
J Drugs Dermatol; 2010 Aug; 9(8):998-1003. PubMed ID: 20684151
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of tretinoin, adapalene and collagenase in an experimental model of wound healing.
Basak PY; Eroglu E; Altuntas I; Agalar F; Basak K; Sutcu R
Eur J Dermatol; 2002; 12(2):145-8. PubMed ID: 11872410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
